The study team will conduct a feasibility, acceptability, and preliminary efficacy trial
comparing Learn to Quit-HIV (n=30) to an app based on U.S. Clinical Practice Guidelines only
(NCI QuitGuide; n=30) among HIV-positive smokers. Both apps will be integrated with NRT and
ongoing HIV clinical care.